Loading…

Clinical significance of IL-18 gene over-expression in AML

Little is known about the clinical significance of interleukin (IL)-18, a novel immunoregulatory cytokine, in acute myeloid leukemia (AML). Using reverse transcriptase polymerase chain reaction (RT-PCR) analysis, levels of IL-18 mRNA were assessed in bone marrow mononuclear cells (BMMC) from 47 adul...

Full description

Saved in:
Bibliographic Details
Published in:Leukemia research 2002-10, Vol.26 (10), p.887-892
Main Authors: Zhang, Bin, Wang, Yong, Zheng, Guo-Guang, Ma, Xiao-Tong, Li, Ge, Zhang, Feng-Kui, Wu, Ke-Fu
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Little is known about the clinical significance of interleukin (IL)-18, a novel immunoregulatory cytokine, in acute myeloid leukemia (AML). Using reverse transcriptase polymerase chain reaction (RT-PCR) analysis, levels of IL-18 mRNA were assessed in bone marrow mononuclear cells (BMMC) from 47 adult patients with de novo or CR AML in order to explore the clinical significance of IL-18. The relationship between expression levels and the established prognostic factors such as age, cytogenetic aberrations, CD34 expression and FAB subtypes was investigated. Either disease status, age or CD34 expression were found to significantly correlate with the expression of IL-18. With respect to FAB cytotypes, expression of IL-18 gene in M4/M5 ( n=15) was statistically higher than that in other subtypes ( n=32, P
ISSN:0145-2126
1873-5835
DOI:10.1016/S0145-2126(02)00025-5